Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Incyte Biosciences Nordic AB
AB
Active
Org 5569334708
Barnhusgatan 3, 111 23
Stockholm
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2013
5-9 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Incyte Biosciences Nordic AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
11M
22M
34M
45M
21M
2020
29M
2021
33M
2022
39M
2023
37M
2024
EBITDA
SEK millions
0M
1M
1M
2M
2M
0M
2020
2M
2021
2M
2022
2M
2023
2M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
21 436
28 815
32 752
38 640
36 679
Staff expenses
—
—
—
−25 665
—
EBITDA
448
1 730
1 545
1 711
1 553
Depreciation & amort.
−181
−178
−103
−268
−512
EBIT
267
1 552
1 442
1 443
1 041
Net financials
−19
−33
−45
296
−26
Profit before tax
248
1 519
1 397
1 739
1 015
Tax
−148
−448
−569
−671
−511
Net profit
100
1 071
828
1 068
504
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
10 111
15 956
16 777
12 941
14 797
Equity
2 162
3 233
4 061
5 129
5 633
Long-term debt
0
0
0
—
0
Short-term debt
7 949
12 723
12 716
7 812
9 164
Total debt
7 949
12 723
12 716
7 812
9 164
Financial ratios
5-year trend
EBITDA margin
4.2%
This company
15.8%
Market median
-73% vs market
2020
2024
Equity ratio
38.1%
This company
38.2%
Market median
+0% vs market
2020
2024
Return on equity
8.9%
This company
18.4%
Market median
-52% vs market
2020
2024
Net profit margin
1.4%
This company
8.1%
Market median
-83% vs market
2020
2024
Asset turnover
2.48×
This company
1.12×
Market median
+121% vs market
2020
2024
Debt / equity
1.63×
This company
0.62×
Market median
-163% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Incyte Biosciences Nordic AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
